SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059622
Filing Date
2024-05-14
Accepted
2024-05-14 16:28:41
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20240331.htm   iXBRL 10-Q 1892237
2 EX-10.1 nuvb-ex10_1.htm EX-10.1 24055
3 EX-10.3 nuvb-ex10_3.htm EX-10.3 481586
4 EX-10.4 nuvb-ex10_4.htm EX-10.4 35576
5 EX-10.5 nuvb-ex10_5.htm EX-10.5 391266
6 EX-31.1 nuvb-ex31_1.htm EX-31.1 15795
7 EX-31.2 nuvb-ex31_2.htm EX-31.2 15879
8 EX-32.1 nuvb-ex32_1.htm EX-32.1 8269
9 EX-32.2 nuvb-ex32_2.htm EX-32.2 7232
10 GRAPHIC img143815571_0.jpg GRAPHIC 9623
11 GRAPHIC img145662613_0.jpg GRAPHIC 9019
  Complete submission text file 0000950170-24-059622.txt   8659171

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvb-20240331.xsd EX-101.SCH 1026447
67 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20240331_htm.xml XML 1459449
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 24944855
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)